"{\n    \"Title\": \"Algoma UniversityConsolidated Statement of Cash Flows\",\n    \"row 1\": \"For the year ended April 30 2018 2017\",\n    \"row 2\": \"Cash flows from operating activities\",\n    \"row 3\": \"Excess of revenues over expenses $ 2,227,596 $ 920,648\",\n    \"row 4\": \"Items not involving cash\",\n    \"row 5\": \"Amortization of tangible capital assets 1,846,587 1,961,780\",\n    \"row 6\": \"Gain on sale of marketable securities (1,718,651) \\u00bb\",\n    \"row 7\": \"Change in unrealized gains on investments (1,999,511) 493,259\",\n    \"row 8\": \"Amortization of deferred contributions (1,190,540) (1,233,944)\",\n    \"row 9\": \"(834,519) 2,141,743\",\n    \"row 10\": \"Changes in non-cash working capital balances\",\n    \"row 11\": \"Accounts receivable - fees 424 31,523\",\n    \"row 12\": \"Accounts receivable - other (652,329) 11,700\",\n    \"row 13\": \"Prepaid expenses and inventory (128,970) 220,627\",\n    \"row 14\": \"Accrued pension obligation (net of change in measurement) (209,000) (47,000)\",\n    \"row 15\": \"Accounts payable and accrued liabilities 290,882 (179,550)\",\n    \"row 16\": \"Fees received in advance (33,230) 28,500 \\u2014\",\n    \"row 17\": \"Deferred government grants and program revenue (463,377) 1,917,581\",\n    \"row 18\": \"(2,030,119) 4,125,124\",\n    \"row 19\": \"Cash flows from investing activities\",\n    \"row 20\": \"Purchase of tangible capital assets (2,615,058) (123,145)\",\n    \"row 21\": \"Purchase (sale) of investments 1,879,941 (705,211)\",\n    \"row 22\": \"Endowment contributions 45,137 66,471\",\n    \"row 23\": \"(689,980) (761,885)\",\n    \"row 24\": \"Cash flows from financing activities\",\n    \"row 25\": \"Repayment of long term debt (767,288) (741,917)\",\n    \"row 26\": \"Deferred capital contributions 1,158,946 1,213\",\n    \"row 27\": \"391,658 (740,704)\",\n    \"row 28\": \"Increase (decrease) in cash and equivalents (2,328,441) 2,622,535\",\n    \"row 29\": \"Cash and cash equivalents, beginning of year 8,428,907 9,806,372\",\n    \"row 30\": \"Cash and cash equivalents, end of year $ 6,100,466 $ 8428907\",\n    \"row 31\": \"The accompanying notes are an integral part of these financial statements.\"\n}"